Lv62
2380 积分 2024-07-14 加入
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
1小时前
待确认
Navigating the landscape of SLE treatment: An expert viewpoint on the rationality and limitations of early biologic intervention
1小时前
待确认
Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus
1小时前
待确认
Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review
1小时前
待确认
Evaluation of the efficacy and safety of belimumab and telitacicept in patients with systemic lupus erythematosus: results from a retrospective, observational study
19天前
已完结
Frequency and predictors for early-achieved lupus low disease activity state in systemic lupus erythematosus patients treated with telitacicept or belimumab: A real-life, single-center observational study
19天前
已完结
BAFF/APRIL expression-guided telitacicept therapy demonstrates superior efficacy in systemic lupus erythematosus patients: a real-world comparative study
20天前
已关闭
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
1个月前
已完结
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
1个月前
已完结
B cell depletion and inhibition in systemic lupus erythematosus
1年前
已完结
皖公网安备34019202002308
